Share This Article:

Comparison of the Folstein Mini Mental State Examination (MMSE) to the Montreal Cognitive Assessment (MoCA) as a Cognitive Screening Tool in an Inpatient Rehabilitation Setting

Abstract Full-Text HTML Download Download as PDF (Size:63KB) PP. 39-42
DOI: 10.4236/nm.2010.12006    16,480 Downloads   39,887 Views   Citations

ABSTRACT

Identifying the presence of cognitive impairment in patients admitted for inpatient rehabilitation is important as it may impact on their ability to participate in a rehabilitation program. The Folstein Mini Mental State Examination (MMSE) has been used by clinicians as a cognitive screening tool for its convenience, even though it is not sensitive, and often fails to detect cognitive impairment. Recently, the Montreal Cognitive Assessment (MoCA) has been developed as a brief cognitive screening tool to detect mild-moderate cognitive impairment. We performed a longitudinal study to compare the utility of the MMSE and MoCA in an inpatient rehabilitation setting. A total of 50 consecutive patients were studied with an average age of 71.7 years of age. The mean test score for MMSE was 26.5 and 22.2 for the MoCA. The Pearson’s correlation coefficient between the scores was 0.695 (p < 0.003). The mean performance time for the MMSE was 7.4 minutes and 14.8 minutes for the MoCA. MMSE did not perform well as a screening instrument for mild cognitive impairment as there were 43 patients who scored 24 or more on MMSE, and 25 patients (58%) scored 25 or less on MoCA, indicating the presence of cognitive impairment. Even though the MoCA takes longer to administer, the additional important information provided indicates that the MoCA should be used rather than the MMSE as a cogni-tive screening tool.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

A. Aggarwal and E. Kean, "Comparison of the Folstein Mini Mental State Examination (MMSE) to the Montreal Cognitive Assessment (MoCA) as a Cognitive Screening Tool in an Inpatient Rehabilitation Setting," Neuroscience and Medicine, Vol. 1 No. 2, 2010, pp. 39-42. doi: 10.4236/nm.2010.12006.

References

[1] S. Nazem, “Montreal Cognitive Assessment Performance in Patients with Parkinson’s Disease with “Normal” Global Cognition According to Mini-Mental State Examination Score,” Journal of the American Geriatrics Society, Vol. 57, No. 2, 2009, pp. 304-308. doi:10.1111/j.1532-5415.2008.02096.x
[2] K. Marder, “Cognitive Impairment and Dementia in Park-inson’s Disease,” Movement disorders, Vol. 25, No. S1, 2010, pp. S110-S116. doi:10.1002/mds.22787
[3] C. Zadikoff, S. H. Foz, D. F. Tang-Wai, T. Thomsen, R. M. de Bie, P Wadia, J. Miyasaki, S. Duff-Canning, A. E. Lang and C. Marras, “A comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in Identify-ing Cognitive Deficits in Parkinson’s Disease,” Movement disorders, Vol. 23, 2007, pp. 297-299. doi:10.1002/mds.21837
[4] M. F. Folstein, S. E. Foltein and P. R. McHugh, “Mini- Mental State: A Practical Method for Grading the Cogni-tive State of Patients for the Clinican,” Journal of Psychi-atric Research, Vol. 12, 1975, pp. 196-198. doi:10.1016/0022-3956(75)90026-6
[5] T. N. Tombaugh and N. J. McIntyre, “The Mini-Mental State Examination: A Comprehensive Review,” Journal of the American Geriatrics Society, Vol. 40, No. 9, 1992, pp. 922-935.
[6] O. Riedel, “Cognitive Impairment in 873 Patients with Idiopathic Parkinson’s Disease: Results from the German Study on Epidemiology of Parkinson’s Disease with De-mentia (GEPAD),” Journal of Neurology, Vol. 255, No. 2, 2008, pp. 255-264. doi:10.1007/s00415-008-0720-2
[7] Z. S. Nasreddine, N. A. Phillips, V. Bedirian, S. Char-bonneau, V. Whitehead, I. Collin, J. L. Cummings and H. Cherthow, “The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool for Mild Cognitive Impairment,” Journal of the American Geriatrics Society, Vol. 53, No. 1-2, 2005, pp. 695-699. doi:10.1111/j.1532-5415.2005.53221.x
[8] D. J. Gill, A. Freshman, J. A. Blender and B. Ravina, “The Montreal Cognitive Assessment as a Screening Tool for Cognitive Impairment in Parkinson’s Disease,” Movement disorders, Vol. 23, No. 7, 2008, pp. 1043-1046. doi:10.1002/mds.22017
[9] S. Hoops, S. Nazem, A. D. Siderowf, J. E. Duda, S. X. Xie, M. B. Stem and D. Weintraub, “Validity of the MoCA and MMSE in the Detection of Mci and De-mentia in Parkinson’s Disease,” Neurology, Vol. 73, 2009, pp. 1738-1745. doi:10.1212/WNL.0b013e3181c34b47

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.